Pfizer works toward equitable and affordable access to COVID-19 vaccines and treatments around the world | Pfizer 2021 Annual Report
![COVID-19 Vaccine Second-Dose Completion and Interval Between First and Second Doses Among Vaccinated Persons — United States, December 14, 2020−February 14, 2021 | MMWR COVID-19 Vaccine Second-Dose Completion and Interval Between First and Second Doses Among Vaccinated Persons — United States, December 14, 2020−February 14, 2021 | MMWR](https://www.cdc.gov/mmwr/volumes/70/wr/social-media/mm7011e2_COVID19VaccineDose2_IMAGE_12Mar21_v4_1200x627.jpg?_=39294)
COVID-19 Vaccine Second-Dose Completion and Interval Between First and Second Doses Among Vaccinated Persons — United States, December 14, 2020−February 14, 2021 | MMWR
![Syringe size and supply issues continue to waste COVID-19 vaccine doses in United States | Science | AAAS Syringe size and supply issues continue to waste COVID-19 vaccine doses in United States | Science | AAAS](https://www.science.org/do/10.1126/science.abi6931/abs/Vaccine_waste_1280x720.jpg)
Syringe size and supply issues continue to waste COVID-19 vaccine doses in United States | Science | AAAS
Should FDA Reconsider Allowing the Pooling of COVID-19 Vaccine Doses to Obtain Additional Doses? | Institute For Safe Medication Practices
![U.S. Global Vaccine Donation Commitment Tops 1.1 Billion Doses; 871,650 More Pfizer Doses Arrived in Jakarta on Thursday - U.S. Embassy & Consulates in Indonesia U.S. Global Vaccine Donation Commitment Tops 1.1 Billion Doses; 871,650 More Pfizer Doses Arrived in Jakarta on Thursday - U.S. Embassy & Consulates in Indonesia](https://d2v9ipibika81v.cloudfront.net/uploads/sites/72/U.S.-Global-Vaccine-Donation-Commitment-Tops-1.1-Billion-Doses-871650-More-Pfizer-Doses-Arrived-in-Jakarta-on-Thursday-1140x684.jpeg)
U.S. Global Vaccine Donation Commitment Tops 1.1 Billion Doses; 871,650 More Pfizer Doses Arrived in Jakarta on Thursday - U.S. Embassy & Consulates in Indonesia
![Interim Estimates of Vaccine Effectiveness of Pfizer-BioNTech and Moderna COVID-19 Vaccines Among Health Care Personnel — 33 U.S. Sites, January–March 2021 | MMWR Interim Estimates of Vaccine Effectiveness of Pfizer-BioNTech and Moderna COVID-19 Vaccines Among Health Care Personnel — 33 U.S. Sites, January–March 2021 | MMWR](https://www.cdc.gov/mmwr/volumes/70/wr/social-media/mm7020e2_EffectivenessPfizerModernaHCP_IMAGE_14May21_1200x627.jpg?_=36679)